Antonella MD - Helius Medical Chief Officer

All Insiders . USA . 
Stock . Helius Medical Technologies . Stakeholders . Insider . Antonella MD
HSDT Stock  USD 0.49  0.03  6.52%   

Insider

Antonella MD is Chief Officer of Helius Medical Technologies
Age 57
Address 642 Newtown Yardley Road, Newtown, PA, United States, 18940
Phone215 944 6100
Webhttps://heliusmedical.com

Helius Medical Management Efficiency

The company has return on total asset (ROA) of (0.7606) % which means that it has lost $0.7606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6197) %, meaning that it created substantial loss on money invested by shareholders. Helius Medical's management efficiency ratios could be used to measure how well Helius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.21 in 2024. Return On Capital Employed is likely to drop to -2.24 in 2024. At this time, Helius Medical's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 384.8 K in 2024, whereas Total Current Liabilities is likely to drop slightly above 1.8 M in 2024.
Helius Medical Technologies currently holds 57 K in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Helius Medical Techn has a current ratio of 2.79, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Helius Medical's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Jason CookBluejay Diagnostics
42
Julie GannonVivos Therapeutics
N/A
John LiuSight Sciences
N/A
Mark KnudsonReShape Lifesciences
75
David MeyerAurora Spine
N/A
Sam ParkSight Sciences
63
Mark FeinbergBluejay Diagnostics
N/A
Sanjay AhujaTivic Health Systems
N/A
DVM DVMReShape Lifesciences
N/A
Ryan SabiaTivic Health Systems
37
Jesse SelnickSight Sciences
N/A
Veronica CaiTivic Health Systems
48
Danielle WatsonHeart Test Laboratories
42
Laurent DuhouxNuwellis
N/A
RaeAnn ByrnesVivos Therapeutics
N/A
Todd HuntsmanVivos Therapeutics
N/A
Laszlo GaramszegiAurora Spine
52
Jonathan ParisRapid Micro Biosystems
48
John WilsonRapid Micro Biosystems
56
Jody DahlmanReShape Lifesciences
N/A
Keith SimeoneSTRATA Skin Sciences
N/A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 19 people. Helius Medical Technologies (HSDT) is traded on NASDAQ Exchange in USA. It is located in 642 Newtown Yardley Road, Newtown, PA, United States, 18940 and employs 22 people. Helius Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Return On Equity-1.62
Return On Asset-0.76

Helius Medical Techn Leadership Team

Elected by the shareholders, the Helius Medical's board of directors comprises two types of representatives: Helius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Helius. The board's role is to monitor Helius Medical's management team and ensure that shareholders' interests are well served. Helius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Helius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, Treasurer, CFO
Lawrence Picciano, Quality Engineering
Antonella MD, Chief Officer
Jeffrey CPA, Treasurer, CFO
Dane Andreeff, CEO President
Brian Bapty, VP of Strategy and Bus. Devel.

Helius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Helius Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.62
Return On Asset-0.76
Operating Margin(17.97) %
Current Valuation(1.73 M)
Shares Outstanding3.73 M
Shares Owned By Insiders0.52 %
Shares Owned By Institutions5.80 %
Number Of Shares Shorted225.38 K
Price To Earning(13.85) X
Price To Book0.45 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY